Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | K224E |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | ATM K224E does not lie within any known functional domains of the Atm protein (UniProt.org). K224E demonstrates the ability to induce expression of TP53 target genes upon DNA damage in patient-derived cells in culture (PMID: 23585524), but demonstrates decreased Atm activity in patient-derived cells in another study (PMID: 36029002), and therefore, its effect on Atm protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM K224E |
Transcript | NM_000051.4 |
gDNA | chr11:g.108244795A>G |
cDNA | c.670A>G |
Protein | p.K224E |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000051.4 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_006718845.3 | chr11:g.108293415A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017791 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_011542843 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_005271561 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_006718845 | chr11:g.108293415A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017792.2 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017791.1 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017792 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_006718845.2 | chr11:g.108293415A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_047426981.1 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.108244795A>G | c.670A>G | p.K224E | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|